Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/15/14 → 8/15/17 |
Funding
- PRA Health Sciences (GS-US-342-1138)
- Gilead Sciences, Inc. (GS-US-342-1138)
Prot #GS-US-342-1138: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic HCV
- Flamm, Steven L (PD/PI)
Project: Research project